These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

180 related items for PubMed ID: 3458531

  • 1. Cardiotoxicity of epirubicin and doxorubicin: assessment by endomyocardial biopsy.
    Torti FM, Bristow MM, Lum BL, Carter SK, Howes AE, Aston DA, Brown BW, Hannigan JF, Meyers FJ, Mitchell EP.
    Cancer Res; 1986 Jul; 46(7):3722-7. PubMed ID: 3458531
    [Abstract] [Full Text] [Related]

  • 2. Attempt to prevent doxorubicin-induced acute human myocardial morphologic damage with acetylcysteine.
    Unverferth DV, Jagadeesh JM, Unverferth BJ, Magorien RD, Leier CV, Balcerzak SP.
    J Natl Cancer Inst; 1983 Nov; 71(5):917-20. PubMed ID: 6580492
    [Abstract] [Full Text] [Related]

  • 3. Anthracycline cardiomyopathy monitored by morphologic changes.
    Billingham ME, Mason JW, Bristow MR, Daniels JR.
    Cancer Treat Rep; 1978 Jun; 62(6):865-72. PubMed ID: 667860
    [Abstract] [Full Text] [Related]

  • 4. [Endomyocardial biopsy as a method of surveilling adriamycin cardiac toxicity. 28 biopsies in 26 patients].
    Bouhour JB, Petitier H, Delajartre AY, Fumoleau P, Rozo L, Nicolas G.
    Arch Mal Coeur Vaiss; 1983 Nov; 76(11):1277-83. PubMed ID: 6419695
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Paclitaxel-induced cardiotoxicity. An ultrastructural study.
    Shek TW, Luk IS, Ma L, Cheung KL.
    Arch Pathol Lab Med; 1996 Jan; 120(1):89-91. PubMed ID: 8554453
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Phase I-II trial of high-dose epirubicin in patients with lymphoma.
    Case DC, Gams R, Ervin TJ, Boyd MA, Oldham FB.
    Cancer Res; 1987 Dec 01; 47(23):6393-6. PubMed ID: 3479245
    [Abstract] [Full Text] [Related]

  • 14. Ultrastructural morphometric analysis of endomyocardial biopsies. Idiopathic dilated cardiomyopathy, anthracycline cardiotoxicity, and normal myocardium.
    Rowan RA, Masek MA, Billingham ME.
    Am J Cardiovasc Pathol; 1988 Dec 01; 2(2):137-44. PubMed ID: 3061409
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Exposure to anthracyclines during childhood causes cardiac injury.
    Lipshultz SE.
    Semin Oncol; 2006 Jun 01; 33(3 Suppl 8):S8-14. PubMed ID: 16781284
    [Abstract] [Full Text] [Related]

  • 19. The effect of mitoxantrone treatment in beagle dogs previously treated with minimally cardiotoxic doses of doxorubicin.
    Tham P, Dougherty W, Iatropoulos MJ, Gordon G, James VC, Hall C, Noble JF.
    Am J Pathol; 1987 Jul 01; 128(1):121-30. PubMed ID: 3605309
    [Abstract] [Full Text] [Related]

  • 20. Phase II study of paclitaxel and epirubicin as first-line therapy in patients with metastatic breast cancer.
    Lück HJ, Thomssen C, du Bois A, Untch M, Lisboa B, Köhler G, Diergarten K.
    Semin Oncol; 1997 Oct 01; 24(5 Suppl 17):S17-35-S17-39. PubMed ID: 9374090
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.